Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study

被引：0
|
作者：
Jean Darloy
Nicolas Segaud
Jean-Hugues Salmon
Jean-Paul Eschard
Vincent Goëb
Xavier Deprez
Marie-Hélène Guyot
Eric Houvenagel
Nicolas Lecuyer
Laurent Marguerie
Samuel Gally
David Pau
Isabelle Idier
Guy Baudens
René-Marc Flipo
机构：
[1] University Hospital of Lille,Rheumatology Department, Hôpital Roger Salengro
[2] University Hospital of Reims,Rheumatology Department, Hôpital Maison Blanche
[3] University Hospital of Amiens-Picardie,Rheumatology Department, Hôpital Nord
[4] Hôpital Jean Bernard,Rheumatology Department
[5] Hospital of Valenciennes,Rheumatology Department
[6] Hôpital Victor Provo,Rheumatology Department
[7] Hospital of Roubaix,Rheumatology Department
[8] Hôpital Saint Philibert,Clinical Operations
[9] Hospital of Lomme,Medical Department
[10] Rheumatology,undefined
[11] Medical office,undefined
[12] Institut François Calot,undefined
[13] Roche SAS,undefined
[14] Chugai Pharma France,undefined
[15] Rheumatology,undefined
[16] Medical office,undefined
来源：
Rheumatology and Therapy | 2019年 / 6卷
关键词：
Administration route; Rheumatoid arthritis; Subcutaneous; Switch; Tocilizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：61 / 75
页数：14
相关论文
共 50 条
  • [1] Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study
    Darloy, Jean
    Segaud, Nicolas
    Salmon, Jean-Hugues
    Eschard, Jean-Paul
    Goeb, Vincent
    Deprez, Xavier
    Guyot, Marie-Helene
    Houvenagel, Eric
    Lecuyer, Nicolas
    Marguerie, Laurent
    Gally, Samuel
    Pau, David
    Idier, Isabelle
    Baudens, Guy
    Flipo, Rene-Marc
    [J]. RHEUMATOLOGY AND THERAPY, 2019, 6 (01) : 61 - 75
  • [2] DESCRIPTION IN REAL-WORLD OF THE EFFICACY AFTER SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS ADMINISTRATION OF TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS. THE ROSWITCH STUDY
    Darloy, J.
    Segaud, N.
    Salmon, J. -H.
    Goeb, V.
    Guyot, M. -H.
    Marguerie, L.
    Chopin, C.
    Gaily, S.
    Idier, I.
    Baudens, G.
    Flipo, R. -M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1384 - 1385
  • [3] Flare After Switching from Intravenous Tocilizumab to Subcutaneous Formulation in Patients with Rheumatoid Arthritis
    Ahn, Soo Min
    Oh, Ji Seon
    Heo, Hyun Mi
    Hong, Seokchan
    Lee, Chang-Keun
    Yoo, Bin
    Kim, Yong-Gil
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1728 - 1730
  • [4] Effectiveness of Tocilizumab after Switching from Intravenous to Subcutaneous Formulation in Patients with Rheumatoid Arthritis: A Single-Centre Experience
    Stojanovic, Sonja
    Stamenkovic, Bojana
    Nedovic, Jovan
    Aleksic, Ivana
    Cvetkovic, Jovana
    [J]. ACTA FACULTATIS MEDICAE NAISSENSIS, 2021, 38 (03) : 247 - 256
  • [5] Evaluation of switching from intravenous to subcutaneous formulation of tocilizumab in patients with rheumatoid arthritis
    Iwamoto, Naoki
    Fukui, Shoichi
    Umeda, Masataka
    Nishino, Ayako
    Nakashima, Yoshikazu
    Suzuki, Takahisa
    Horai, Yoshiro
    Nonaka, Fumiaki
    Okada, Akitomo
    Koga, Tomohiro
    Kawashiri, Shin-ya
    Fujikawa, Keita
    Aramaki, Toshiyuki
    Ichinose, Kunihiro
    Hirai, Yasuko
    Tamai, Mami
    Nakamura, Hideki
    Terada, Kaoru
    Nakashima, Munetoshi
    Mizokami, Akinari
    Origuchi, Tomoki
    Eguchi, Katsumi
    Ueki, Yukitaka
    Kawakami, Atsushi
    [J]. MODERN RHEUMATOLOGY, 2016, 26 (05) : 662 - 666
  • [6] Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis
    Ogata, Atsushi
    Atsumi, Tatsuya
    Fukuda, Takaaki
    Hirabayashi, Yasuhiko
    Inaba, Masaaki
    Ishiguro, Naoki
    Kai, Motokazu
    Kawabata, Daisuke
    Kida, Daihei
    Kohsaka, Hitoshi
    Matsumura, Ryutaro
    Minota, Seiji
    Mukai, Masaya
    Sumida, Takayuki
    Takasugi, Kiyoshi
    Tamaki, Shigenori
    Takeuchi, Tsutomu
    Ueda, Atsuhisa
    Yamamoto, Kazuhiko
    Yamanaka, Hisashi
    Yoshifuji, Hajime
    Nomura, Akira
    [J]. ARTHRITIS CARE & RESEARCH, 2015, 67 (10) : 1354 - 1362
  • [7] Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study
    Ayaz, Nuray Aktay
    Karadag, Serife Gul
    Koc, Rahime
    Demirkan, Fatma Gul
    Cakmak, Figen
    Sonmez, Hafize Emine
    [J]. RHEUMATOLOGY INTERNATIONAL, 2020, 40 (07) : 1111 - 1116
  • [8] Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study
    Nuray Aktay Ayaz
    Şerife Gül Karadağ
    Rahime Koç
    Fatma Gül Demirkan
    Figen Çakmak
    Hafize Emine Sönmez
    [J]. Rheumatology International, 2020, 40 : 1111 - 1116
  • [9] Effectiveness and Tolerability of Subcutaneous Tocilizumab in Rheumatoid Arthritis Patients Switched From Intravenous Tocilizumab: Results From the Extension Period of the Musashi Study
    Ogata, Atsushi
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S555 - S555
  • [10] STABLE EFFICACY AND SAFETY AFTER SWITCHING FROM TOCILIZUMAB INTRAVENOUS TO SUBCUTANEOUS IN RHEUMATOID ARTHRITIS: RESULTS OF A COHORT OF 200 PATIENTS
    Joffres, L.
    Ricard, E.
    Gillion, C. Pereira
    Herbette, M.
    Lucas, C.
    Cren, J. B.
    Bergeal, E.
    Maugars, Y.
    Saillot, C.
    Goupille, P.
    Saraux, A.
    Perdriger, A.
    Bouvard, B.
    Gervais, E. Solau
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1191 - 1191
12345